Andréia Leopoldino

Dr. Andréia Leopoldino

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2013 in FEBS Open Bio
Verified
Journal Article
Open access
LALuciana Oliveira de Almeida
Luciana Oliveira de Almeida
AAAline C. Abrahao
Aline C. Abrahao
LRLuciana K. Rosselli-Murai
Luciana K. Rosselli-Murai
FGFernanda S. Giudice
Fernanda S. Giudice
Chiara ZagniChiara Zagni
Chiara Zagni
RCRogerio Castilho
Rogerio Castilho
Cisplatin‐based chemotherapy is the standard treatment of choice for head and neck squamous cell carcinoma (HNSCC). The efficiency of platinum‐based therapies is directly influenced by the development of tumor resistance. Multiple signaling pathways have been linked to tumor resistance, including activation of nuclear factor kappa B (NFκB). We explore a novel mechanism by which NFκB drives HNSCC resistance through histone modifications. Post‐translational modification of histones alters chromatin structure, facilitating the binding of nuclear factors that mediate DNA repair, transcription, and other processes. We found that chemoresistant HNSCC cells with active NFκB signaling respond to chemotherapy by reducing nuclear BRCA1 levels and by promoting histone deacetylation (chromatin compaction). Activation of this molecular signature resulted in impaired DNA damage repair, prolonged accumulation of histone γH2AX and increased genomic instability. We found that pharmacological induction of histone acetylation using HDAC inhibitors prevented NFκB‐induced cisplatin resistance. Furthermore, silencing NFκB in HNSCC induced acetylation of tumor histones, resulting in reduced chemoresistance and increased cytotoxicity following cisplatin treatment. Collectively, these findings suggest that epigenetic modifications of HNSCC resulting from NFκB‐induced histone modifications constitute a novel molecular mechanism responsible for chemoresistance in HNSCC. Therefore, targeted inhibition of HDAC may be used as a viable therapeutic strategy for disrupting tumor resistance caused by NFκB.

1 October 2015 in Journal of Biomedical Nanotechnology
Verified
Journal Article
Closed access
LHLucas A. Huber
Lucas A. Huber
TPTatiana A. Pereira
Tatiana A. Pereira
DRDanielle N. Ramos
Danielle N. Ramos
LRLucas C. D. Rezende
Lucas C. D. Rezende
FEFlávio S. Emery
Flávio S. Emery
Renata Fonseca Vianna  LopezRenata Fonseca Vianna Lopez
Renata Fonseca Vianna Lopez
The topical administration of chemotherapeutics is a promising approach for the treatment of skin cancer; however, different pharmaceutical strategies are required to allow large amounts of drug to penetrate tumors. This work examined the potential of the anodic iontophoresis of doxorubicin-loaded cationic solid lipid nanoparticles (DOX-SLN) to increase the distribution and tumor penetration of DOX. A double-labeled cationic DOX-SLN composed of the lipids stearic acid and monoolein and a new BODIPY dye was prepared and characterized. The skin distribution and penetration of DOX were evaluated in vitro using confocal microscopy and vertical diffusion cells, respectively. The antitumor potential was evaluated in vivo through the anodic iontophoresis of DOX-SLN in squamous cell carcinoma induced in nude BALB/c mice. The encapsulation of DOX drastically altered the DOX partition coefficient and increased the distribution of DOX in the lipid matrix of the stratum corneum (SC). The association with iontophoresis created high-concentration drug reservoir zones in the follicles of the skin. Although the iontophoresis of a DOX solution increased the penetration of DOX in the viable epidermis by approximately 4-fold, the iontophoresis of cationic DOX-SLN increased the DOX penetration by approximately 50-fold. In vivo, the DOX-SLN iontophoretic treatment was effective in inhibiting tumor cell survival and tumor growth and was accompanied by an increase in keratinization and consequent cell death. These results indicate a strong and synergic effect of iontophoresis with DOX-SLN and provide a potential strategy for the treatment of skin cancer.

1 January 2005 in Cancer Research
Verified
Journal Article
Open access
PDF file
CBClarisse Bavoux
Clarisse Bavoux
ALAndréia Leopoldino
Andréia Leopoldino
VBValérie Bergoglio
Valérie Bergoglio
JOJiyang O-Wang
Jiyang O-Wang
TOTomoo Ogi
Tomoo Ogi
CCChristophe Cazaux
Christophe Cazaux
It is currently widely accepted that genetic instability is key to cancer development. Many types of cancers arise as a consequence of a gradual accumulation of nucleotide aberrations, each mutation conferring growth and/or survival advantage. Genetic instability could also proceed in sudden bursts leading to a more drastic upheaval of structure and organization of the genome. Genetic instability, as an operative force, will produce genetic variants and the greater the instability, the larger the number of variants. We report here that the overexpression of human DNA polymerase κ, an error-prone enzyme that is up-regulated in lung cancers, induces DNA breaks and stimulates DNA exchanges as well as aneuploidy. Probably as the result of so many perturbations, excess polymerase κ favors the proliferation of competent tumor cells as observed in immunodeficient mice. These data suggest that altered regulation of DNA metabolism might be related to cancer-associated genetic changes and phenotype.

20 February 2014 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
LSLays M Sobral
Lays M Sobral
LSLucas Oliveira Sousa
Lucas Oliveira Sousa
Ricardo D. ColettaRicardo D. Coletta
Ricardo D. Coletta
Hamilton CabralHamilton Cabral
Hamilton Cabral
LGLewis J Greene
Lewis J Greene
ALAndréia Leopoldino
Andréia Leopoldino
SET/I2PP2A is a multifunctional protein that is up-regulated in head and neck squamous cell carcinoma (HNSCC). The action of SET in HNSCC tumorigenicity is unknown.

1 March 2020 in Cells
Verified
Journal Article
Open access
PDF file
LFLais Brigliadori Fugio
Lais Brigliadori Fugio
FCFernanda B. Coeli-Lacchini
Fernanda B. Coeli-Lacchini
ALAndréia Leopoldino
Andréia Leopoldino
For decades, sphingolipids have been related to several biological functions such as immune system regulation, cell survival, and proliferation. Recently, it has been reported that sphingolipids could be biomarkers in cancer and in other human disorders such as metabolic diseases. This is evidenced by the biological complexity of the sphingolipids associated with cell type-specific signaling and diverse sphingolipids molecules. As mitochondria dynamics have serious implications in homeostasis, in the present review, we focused on the relationship between sphingolipids, mainly ceramides and sphingosine-1-phosphate, and mitochondrial dynamics directed by fission, fusion, and mitophagy. There is evidence that the balances of ceramides (C18 and C16) and S1P, as well as the location of specific ceramide synthases in mitochondria, have roles in mitophagy and fission with an impact on cell fate and metabolism. However, signaling pathways controlling the sphingolipids metabolism and their location in mitochondria need to be better understood in order to propose new interventions and therapeutic strategies.

1 April 2005 in Neoplasia
Verified
Journal Article
Open access
CACharles Anacleto
Charles Anacleto
ALAndréia Leopoldino
Andréia Leopoldino
BRBenedito Rossi
Benedito Rossi
FSFernando A. Soares
Fernando A. Soares
ALAdemar Lopes
Ademar Lopes
SPSérgio D.J. Pena
Sérgio D.J. Pena
It has been proposed that human colorectal tumors can be classified into two groups: one in which methylation is rare, and another with methylation of several loci associated with a "CpG island methylated phenotype (CIMP)," characterized by preferential proximal location in the colon, but otherwise poorly defined. There is considerable overlap between this putative methylator phenotype and the well-known mutator phenotype associated with microsatellite instability (MSI). We have examined hypermethylation of the promoter region of five genes (DAPK, MGMT, hMLH1, p16INK4a, and p14ARF) in 106 primary colorectal cancers. A graph depicting the frequency of methylated loci in the series of tumors showed a continuous, monotonically decreasing distribution quite different from the previously claimed discontinuity. We observed a significant association between the presence of three or more methylated loci and the proximal location of the tumors. However, if we remove from analysis the tumors with hMLH1 methylation or those with MSI, the significance vanishes, suggesting that the association between multiple methylations and proximal location was indirect due to the correlation with MSI. Thus, our data do not support the independent existence of the so-called methylator phenotype and suggest that it rather may represent a statistical artifact caused by confounding of associations.